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Abstract
Regional variation in sweating over the human body is widely recognized yet variation in vasomotor responses and 
mechanisms causing this variation remain unclear. This study aimed to explore the relation between regional sweating 
rates (RSR) and skin blood flow (SkBF) responses to thermal and pharmacological stimuli in young, healthy subjects. 
In nine subjects (23 ± 3 yr), intradermal microdialysis (MD) probes were inserted into the ventral forearm, abdomen, 
thigh, and lower back and perfused with lactated Ringer solution. RSR over each MD membrane were measured using 
ventilated capsules with a laser Doppler probe housed in each capsule for measurement of red cell flux (laser Doppler 
flux, LDF) as an index of SkBF. Subjects completed a whole body heating protocol to 1°C rise in oral temperature and 
an acetylcholine dose response (ACh 1 X 10-7-0.1 M; mean skin temperature 34°C). Maximal LDF were obtained at the 
end of both protocols (50 mM sodium nitroprusside).During heating RSR varied among sites (P < 0.0001) and was 
greater on the back versus other sites (P < 0.05), but LDF was similar between sites (P = 0.343). RSR and SkBF showed 
a strong relation during initial (arm: r = 0.77 ± 0.09, thigh: r = 0.81 ± 0.08, abdomen: r = 0.89 ± 0.04, back: r =
1.86 ± 0.04) but not latter stages of heating. No differences in RSR (P = 0.160) or SkBF (LDF, P = 0.841) were observed 
between sites during ACh perfusion. Taken together, these data suggest that increases in SkBF are necessary to initiate 
and increase sweating, but further rises in RSR are not fully dependent on SkBF in a dose- response manner. 
Furthermore, RSR cannot be explained by cholinergic sensitivity or variation in SkBF.
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gional variation in sweating over the human body is widely recog- 
nized yet variation in vasomotor responses and mechanisms causing 
this variation remain unclear. This study aimed to explore the relation 
between regional sweating rates (RSR) and skin blood flow (SkBF) 
responses to thermal and pharmacological stimuli in young, healthy 
subjects. In nine subjects (23 ± 3 yr), intradermal microdialysis (MD) 
probes were inserted into the ventral forearm, abdomen, thigh, and 
lower back and perfused with lactated Ringer solution. RSR over each 
MD membrane were measured using ventilated capsules with a laser 
Doppler probe housed in each capsule for measurement of red cell 
flux (laser Doppler flux, LDF) as an index of SkBF. Subjects com- 
pleted a whole body heating protocol to 1°C rise in oral temperature 
and an acetylcholine dose response (ACh 1 X 10-7-0.1 M; mean skin 
temperature 34°C). Maximal LDF were obtained at the end of both 
protocols (50 mM sodium nitroprusside).During heating RSR varied 
among sites (P < 0.0001) and was greater on the back versus other 
sites (P < 0.05), but LDF was similar between sites (P = 0.343). RSR 
and SkBF showed a strong relation during initial (arm: r = 0.77 ± 
0.09, thigh: r = 0.81 ± 0.08, abdomen: r = 0.89 ± 0.04, back: r = 
1.86 ± 0.04) but not latter stages of heating. No differences in RSR 
(P = 0.160) or SkBF (LDF, P = 0.841) were observed between sites 
during ACh perfusion. Taken together, these data suggest that in- 
creases in SkBF are necessary to initiate and increase sweating, but 
further rises in RSR are not fully dependent on SkBF in a dose- 
response manner. Furthermore, RSR cannot be explained by cholin- 
ergic sensitivity or variation in SkBF. 
sweating; skin blood flow; regional; laser Doppler flowmetry; micro- 
dialysis 
IN YOUNG, HEALTHY INDIVIDUALS, challenges to thermoregulatory 
homeostasis elicit significant increases in skin blood flow 
(SkBF) and eccrine sweating. Cutaneous vasodilation provides 
the heat required to evaporate sweat from the skin surface and 
is partially reflected by skin temperature. Regional variation in 
sweating over the body is well documented (3, 5, 6, 19, 23–25, 
28, 38), however, cannot be explained by regional eccrine sweat 
gland density (28, 37) or regional skin temperature (Tsk) (3). 
This discrepancy may result from variations in individual 
sweat gland output and/or sudomotor sensitivity (23–25).Vari- 
ation in SkBF between regions is present both at a basal level 
and during pharmacologically induced maximal dilation (7). 
Arterial occlusion of a limb causes a decrease in sweating rate 
during either whole body heating or administration of sudorific 
agents (2, 4, 30). More recently, manipulation of local skin 
temperature has been shown to alter local sweating rate by 
independent effects of SkBF and local skin temperature, sup- 
porting a relation between the two responses (40). 
Thermoregulatory reflex cutaneous vasodilation is mediated 
via the corelease of ACh, acting to stimulate sweating by 
stimulating sweat gland muscarinic receptors, and an unknown 
cotransmitter from sympathetic cholinergic nerves that medi- 
ates cutaneous vasodilation (15). Putative neurotransmitters 
include vasoactive intestinal peptide (1), substance P (41), and 
calcitonin gene-related peptide (31), acting in part through 
nitric oxide-dependent cGMP mechanisms (16) to mediate 
reflex cutaneous vasodilation. A functional relationship be- 
tween cutaneous vasodilation and eccrine sweating has long 
been suggested (21), with observations of vasodilation and 
augmented sweating upon corelease of vasoactive intestinal 
peptide (VIP) and ACh from cholinergic secretomotor nerves 
(42). However, a complete understanding of the mechanisms of 
reflex cutaneous vasodilation and its relationship with eccrine 
sweating remain unclear. 
The present study was conducted largely as a follow up from 
sweat mapping data thath reported highly detailed sweating 
patterns over large surface areas of the human body (34, 35). 
The significant variation in regional sweating rates (RSR) over 
the body could not be explained by variation in skin temper- 
ature. In consideration of the reported effects of local SkBF 
(40), skin temperature, and arterial occlusion on local sweating 
rates, the present study aimed to explore the relation between 
regional sweating and SkBF responses to both thermal and 
pharmacological stimuli in young, healthy subjects. We hy- 
pothesized that regions of highest sweating rate would coincide 
with regions of highest SkBF during whole body heating. We 
further hypothesized that body regions with the greatest sweat 
rates and skin blood flows would show the greatest cholinergic 
sensitivity. 
 
METHODS 
Subjects 
Experimental protocols were approved by the Institutional Review 
Board at The Pennsylvania State University and conformed to the 
guidelines set forth by the Declaration of Helsinki. Verbal and written 
consent were voluntarily obtained from all subjects before participa- 
tion. Nine young (23 ± 2 yr, 5 men and 4 women) subjects partici- 
pated in the study. Subjects underwent a complete medical screening, 
including blood chemistry, complete lipid, renal, and liver enzyme 
profile evaluation (Quest Diagnostics Nichol Institute, Chantilly, VA), 
resting electrocardiogram, and physical examination. All subjects 
were screened for the presence of cardiovascular, dermatological, and 
neurological disease. Subjects were nonsmokers, nondiabetic, nor- 
mally active (neither sedentary nor highly exercise trained), and were 
not taking medications including antihypertensives or other drugs that 
may affect the cardiovascular system, including antioxidants, hor- 
mone replacement therapy, or oral contraceptives. All young women 
were normally menstruating and were tested during the early follicular 
phase (days 1–7) of their menstrual cycle. All subjects completed a 
graded exercise test (Bruce protocol) on a semirecumbent bike to 
determine V̇ O2   peak in a room maintained at 23°C, 40% relative 
humidity. Subjects underwent a dual X-ray absorptiometry (DEXA) 
scan for assessment of regional body composition. Subject character- 
istics are presented in Table 1. 
Instrumentation 
Protocols were performed in a thermoneutral laboratory with the 
subjects in a supine position. Four intradermal microdialysis (MD) 
fibers (MD 2000,  Bioanalytical Systems)  (10 mm,  20-kDa cutoff 
membrane) were inserted as previously described (8), into the ventral 
forearm, abdomen, thigh, and lower back. Foam was placed under- 
neath the subject to prevent pressure being placed on the equipment 
and measurement site at the lower back. Fibers were inserted follow- 
ing temporary anesthesia of each site using ethyl chloride spray 
(Gebauer, Cleveland, OH) (11). Sites were selected based on high and 
low sweat regions from whole body sweat maps and using similar 
anatomical measurements to determine MD fiber placement (34, 35). 
Briefly, the abdomen site was identified on the left side of the body as 
midway between the anterior superior iliac spine and the navel; the 
thigh site was calculated as 0.6 times the upper leg length (distance 
from anterior superior iliac spine to the proximal edge of the patella); 
the lower back site was identified on the left side of the body at the 
height of the anterior superior iliac spine, 5–10 cm lateral to the 
vertebrae. Initial insertion trauma was allowed to subside for 60 –90 
min, during which time lactated Ringer solution was perfused through 
all fibers at a rate of 2 µl/min (Bioanylitical Systems Bee hive and 
Baby Bee microinfusion pumps, West Lafayette, IN). Arterial blood 
pressure was measured via brachial auscultation every 5 min follow- 
ing hyperemia and throughout the protocol. Mean arterial pressure 
(MAP) was calculated as [1/3 systolic blood pressure + (2/3 diastolic 
blood pressure)]. SkBF was expressed as laser-Doppler flux (LDF) as 
an indication of absolute flow. 
Whole body heating was achieved using a water-perfused suit that 
covered the entire body with exception to the head, hands, feet, and a 
distal portion of the experimental arm. Incisions were made in the 
water-perfused suit at each MD fiber site except the arm to prevent the 
sweat capsule and LDF probes being covered and to maintain contact 
between the skin and suit surrounding each site. Local skin temper- 
ature (Tsk) was continuously measured at six sites using copper- 
constantan thermocouples (calf, thigh, abdomen, chest, upper arm, 
and upper back) and an unweighted mean skin temperature (Tsk mean) 
was calculated. Oral temperature (Tor) was measured as an index of 
body core temperature (Tcore) using a thermistor placed in the sub- 
lingual sulcus throughout baseline and whole body heating. All 
thermocouples and the sublingual thermistor were calibrated in a 
heated water bath against a glass, mercury thermometer before each 
experiment. The sublingual probe was inserted and positioned at the 
site of highest temperature at the sublingual sulcus, before being taped 
in place. Subjects were instructed to maintain a closed mouth for the 
duration of the baseline and heating protocol, during which time Tor
was closely monitored. Mean body temperature (Tbody) was calculated 
as Tbody = (0.9 X Tor) + (0.1 X mean Tsk). An index of SkBF was 
measured using laser-Doppler flowmetry probes (MoorLAB, Moor 
Instruments) placed over each MD site measuring cutaneous red blood 
cell flux, which was recorded continuously during the experiment. 
Total body sweating rate was determined from the change in body 
mass during whole body heating using a scale accurate to ± 10 g 
(SECA model 770 1321143). Values were not corrected for metabolic 
and respiratory losses. Local sweating rates were measured using 
ventilated capsules with compressed medical grade nitrogen used as 
the perfusion gas (20, 32) specifically manufactured so that sweating 
rate and LDF could be measured simultaneously. Sweat capsules 
(4.46 cm2 surface area) were positioned over the center of the 
membrane portion of each MD fiber. The temperature and humidity of 
the air flowing out of the capsules were measured using capacitance 
hygrometers that were calibrated by the manufacturer and regularly 
calibrated using reference solutions of known temperature and humid- 
ity (model HMT330, Vaisala, Helsinki, Finland). Sweating rate was 
calculated based on the change in relative humidity of the air as it 
passed through the capsule (ilrh), the airflow rate (AF), the density of 
saturated steam at the given temperature (D), and the capsules surface 
area (SA), using the following equation: SR = [AF X (ilrh/100) X 
D]/SA. 
 
Experimental Protocols 
Acetylcholine dose response. After MD fiber insertion and resolu- 
tion of insertion trauma, baseline data were collected for 20 min. 
Immediately after baseline measurement, Tsk was clamped at 34°C 
during perfusion of seven ascending concentrations of ACh at a rate 
of 2 µl/min for 10 min each: 1 X 10-7 to 1 X 10-1 M dissolved in 
Ringer solution in 10-fold increments. This amount of time allowed 
for a plateau in SkBF at each concentration of ACh. After completion 
of the ACh dose response, 50 mM sodium nitroprusside (SNP) was 
perfused through all sites at a rate of 4 µl/min to induce maximal 
cutaneous vasodilation (LDF) (10, 14). 
Whole body heating. Upon arrival to the laboratory subjects pro- 
vided a urine sample for assessment of hydration status via urine 
specific gravity and osmolality, and body mass was recorded. Proto- 
cols were performed on the same body regions as the ACh dose 
response and separated by at least 1 wk to allow skin to fully heal 
between trials. After MD fiber insertion and resolution of insertion 
trauma, baseline data were collected for 20 min with mean Tsk 
maintained at thermoneutral using a water-perfused suit (34°C). After 
collection of baseline data, 50°C water was perfused through the suit 
to elevate Tor by 1°C, after which Tor was clamped for 5 min by 
reducing the temperature of the water perfusing the suit. After 10 min 
of steady-state LDF values, water perfusing the suit was returned to 
34°C and 50 mM SNP (Nitropress; Abott Laboratories, Chicago, IL) 
was perfused through each MD site at a rate of 4 µl/min to obtain 
maximal cutaneous vasodilation (LDF) values (9, 26). 
 
Data and Statistical Analysis 
Data were digitalized at 40 Hz, recorded, and stored for offline 
analysis using Windaq software and Dataq data acquisition system 
(Windaq; Dataq Instruments, Akron, OH). Baseline values were 
determined as the last 5 min before commencing whole body heating 
or ACh dose response. Local sweating and SkBF data are presented as 
mean values over 60 s at each 0.1°C rise in oral temperature through- 
out the heating protocol or for each ACh dose. The relation between 
SkBF and RSR was considered in two stages, defined as early (BL to 
0.5°CilTor) and late (0.6 to 1.0°CilTor) phases of whole body heating. 
Table 1. Participant characteristics 
Subjects (Male, 
Female) Age, yr   BMI, kg/m2        AD, m2
Total Body 
fat, % 
Systolic BP, 
mmHg 
Diastolic BP, 
mmHg MAP, mmHg   HbA1c, mmol/mol   HDL, mg/dl    LDL, mg·dl 
V̇ O2max, 
ml · kg-1 · min-1
(5, 4) 23 ± 3 25 ± 4 1.95 ± 0 27 ± 6 108 ± 10 69 ± 8 82 ± 8 35 ± 2 66 ± 21 81 ± 27 35 ± 9 
Values are means ± SD. BMI. body mass index; AD, DuBois body surface area; BP, blood pressure; MAP, mean arterial pressure; HbA1c, plasma glucose 
concentration; HDL, high-density lipoprotein; LDL, low-density lipoprotein. 
Dose-response curves for LDF and RSR at each site during the ACh 
dose-response  protocol  were  constructed  using  a  nonlinear  fitting A Arm
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technique, with a Hill slope of 1, from which the effective concen- 
tration eliciting 50% of the maximal response (EC50) was calculated 
(Sigma Plot 11.0) (39). Maximal SkBF values were averaged over a 
stable 60-s plateau during perfusion of 50 mM SNP. Sweating and 
cutaneous vasodilation thresholds for the heating protocol were de- 
termined by two independent investigators who were blinded during 
analysis. LDF and sweating data for each protocol were analyzed 
using a two-way, mixed model, repeated measures ANOVA [site X 
heating phase (ilTor) or ACh dose; proc mix SAS 9.2]. Specific 
planned comparisons were performed when appropriate to determine 
where differences between groups and sites occurred with appropriate 
Bonferroni correction. The level of significance was set at a = 0.05. 
Values are presented as means ± SE. 
RESULTS 
Acetylcholine Dose Response 
No differences in SkBF (LDF, P = 0.841) or sweating rate 
(P = 0.160) were observed between sites during the ACh dose-
response protocol (Fig. 1). To examine the relation be- tween 
absolute SkBF and RSR, LDF values are presented. When 
calculated as %CVCmax no differences in the pattern of SkBF 
between sites were observed from that of the LDF data, 
therefore the normalized data are not presented. Both sweating 
rate and SkBF increased similarly between sites with ascending 
doses of ACh (site X phase interaction: RSR, P = 0.418; SkBF, 
P = 0.574). Vasodilation occurred at a lower ACh 
concentration compared with sweating at all sites, and no 
correlation was present between RSR and SkBF within any 
site. The EC50  of the ACh dose-response curves (Table 2) for 
SkBF differed between regional sites (P = 0.027), being lower 
on the thigh and back compared with the arm (P < 0.05), and 
greater on the thigh versus the abdomen (P < 0.05). EC50
values were not calculated for RSR due to the highest dose of 
ACh not eliciting a maximal sweating rate. No differences in 
RSR or SkBF were present between sites during perfusion of 
SNP (Table 2). 
 
Passive Heating 
Absolute Tor increased from 36.75 ± 0.09°C to 37.77 ± 
0.09°C throughout the heating protocol (P < 0.001), and mean 
Tsk increased from 35.24 ± 0.26°C to 38.78 ± 0.25°C (P < 
0.001). MAP did not change significantly during the heating 
protocol (MAP: baseline 73 ± 4 mmHg, 1°CilTor 77 ± 4 
mmHg, P = 0.177). The duration of passive heating to 
1°CilTor was 88 ± 9 min and did not correlate strongly with 
total lean mass, total body fat, body surface area, or V̇ O2max. 
Total sweat loss during the whole body heating protocol was 
767 ± 84 g·m-2·h-1. Within-subject analysis indicated strong 
correlation coefficients for SkBF and RSR at all sites during 
the early stage (BL-0.5°CilTor) of heating (arm: r = 0.77 ± 
0.09, thigh: r = 0.81 ± 0.08, abdomen: r = 0.89 ± 0.04, lower 
back: r = 0.86 ± 0.04) and only at the arm during the latter 
stage (0.6 –1°CilTor) of heating (arm: r = 0.70 ± 0.07, thigh: 
0.02 20 
0.00 0 
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Log-Molar Concentration of Acetylcholine Fig. 1. Regional sweating rates (mg·min-1·cm-2) and laser-Doppler flux 
(LDF) during local administration of 10-7 to 10-1 M acetylcholine at ventral 
forearm (A), thigh (B), abdomen (C), and lower back (D). 
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Table 2.  Relative thresholds (ilTor from baseline, °C) for the onset of cutaneous vasodilation and sweating, and maximal 
vasodilation (LDF) during infusion of 50 Mm SNP at four sites in young subjects 
Relative Thresholds (°C Above 
Baseline Tor) During 
Heating Protocol LDF EC50  Values (Log-Molar Maximal LDF Values (50 mM SNP) 
Concentration), ACh 
Site Vasodilation Sweating Dose Response Heating protocol ACh dose response 
Arm (ventral forearm) 0.2 ± 0.1 0.3 ± 0.1 -4.39 ± 0.31 112 ± 10† 104 ± 8 
Abdomen 0.2 ± 0.1 0.2 ± 0.0 -3.47 ± 0.22§ 139 ± 9‡ 106 ± 9 
Thigh 0.2 ± 0.1 0.2 ± 0.0* -4.11 ± 0.21* 113 ± 15 107 ± 6 
Lower back 0.1 ± 0.0 0.1 ± 0.0* -3.38 ± 0.32* 79 ± 7 112 ± 14 
Values are means ± SE. LDF, laser Doppler flux; SNP, sodium nitroprusside. Values significantly different from arm site, *P < 0.05; significantly different 
from back site, †P < 0.05, ‡P < 0.001; significantly different from thigh, §P < 0.05. 
r = 0.23 ± 0.21, abdomen: r = 0.03 ± 0.22, lower back: r = 
0.39 ± 0.19). 
Within-subject analysis of the relation between RSR, SkBF, 
and body composition data (Table 3) at 0.5 and 1.0°CilTor 
showed considerable variation, with a strong correlation be- 
tween regional lean mass versus RSR only (0.5°CilTor r = 
0.79, 1.0°CilTor  r = 0.64). 
Figure 2 illustrates mean RSR and LDF as an index of SkBF 
during the heating protocol. Since MAP did not change signif- 
icantly throughout the protocol, presentation of absolute SkBF 
data are shown as LDF units for comparison with regional 
sweating rates. RSR varied between sites (P < 0.0001) 
throughout the heating protocol, but no differences were pres- 
ent at baseline. RSR was greater on the lower back compared 
with the other sites throughout heating (all sites P < 0.05). 
Differences in RSR between the remaining sites varied with 
increasing Tor, showing greater RSR on 1) the thigh versus arm 
during the initial stages of heating (0.2– 0.3°C ilTor), 2) abdo- 
men versus arm from 0.2 to 0.5°C ilTor, and 3) the abdomen 
versus thigh during the latter stages of heating (0.7–1.0°C ilTor). 
The sweating threshold on the arm (0.3°C ilTor from 
baseline) was higher than the thigh and the lower back (Table 
2); however, no differences in cutaneous vasodilation thresh- 
olds were evident between sites. Unlike the delay in sweating 
response observed upon exposure to whole body heating, 
cutaneous vasodilation occurred at the onset of the heating 
stimulus and continued to increase with elevations in Tor 
(heating phase, P < 0.001). SkBF reached a plateau at 0.6°C 
ilTor at the abdomen compared with a steadier rise at the arm, 
thigh, and lower back, although no differences in LDF were 
observed between sites (site, P = 0.343). Maximal SkBF 
elicited from perfusion of 50 mM SNP was significantly lower 
on the back compared with the abdomen (P < 0.001) and the 
arm (P < 0.05) (Table 2). When normalized to maximal values 
(Fig. 3), SkBF showed similar patterns to those observed in the 
absolute  data  (Fig.  2),  with  exception  to  the  lower  back. 
Table 3.  Regional body composition corresponding to skin 
blood flow and sweating rate measurement sites 
Regional Body Composition 
Because of the low maximal SkBF on the back, the normalized 
SkBF values were significantly higher on the back throughout 
heating compared with the other sites. No differences in 
maximal SkBF were present between the whole body heating 
and ACh dose-response protocols at any site. 
 
DISCUSSION 
The major new fi of the present study were that 
1) RSR differed between body regions in response to thermal
but not pharmacological stimuli, 2) elevations in absolute 
SkBF in response to either passive heating or ACh did not 
differ between regions, 3) RSR correlated strongly with abso- 
lute regional SkBF during the initial but not the latter stages of 
whole body heating, and 4) no significant correlation was 
observed between regional sweating rate and SkBF with as- 
cending ACh doses. 
The present data identify considerable regional differences 
in sweating rates at different body sites during passive heating, 
which are consistent with patterns of distribution identified in 
models of both passive and exercise-induced hyperthermia (13, 
24, 35), using varied measurement techniques. Specifically, 
RSR were highest on the lower back and lowest on the arm and 
thigh, supporting observations from recent studies of high 
versus low sweating rates on central versus peripheral body 
regions, respectively (23, 24, 34, 35). Despite wide recognition 
of these regional differences, the physiological underpinnings 
remain unclear. The most likely explanations underlying this 
phenomenon include variation in sweat gland output, neural 
innervation (sympathetic nerve activity), and local glandular 
sensitivity. The present study examined regional differences in 
sweat gland cholinergic sensitivity via local delivery of ACh in 
a dose-dependent manner. No differences in RSR were ob- 
served between the four sites at any ACh concentration, sug- 
gesting similar cholinergic sensitivities at the regions mea- 
sured. The RSR elicited by the ACh dose-response protocol are 
low compared with literature values using similar techniques 
(18, 33). This may be accounted for by the skin surface area 
covered by the capsule (4.46 cm-2) compared with the 0.5-cm2
capsules used over MD fibers by other authors (18). When set 
volumes of distilled water (5–20 µl) are injected into both 
capsules, the area under the curve is similar (unpublished pilot 
data). When adjusted for surface area (multiply by 8.9), the 
RSR values in the present study are comparable with those of 
Site Fat, kg Lean, kg Fat, % 
Left Arm 
Trunk 
Right Leg 
Total Body 
0.99 ± 0.11 
8.71 ± 1.20 
4.46 ± 0.46 
20.52 ± 2.24 
2.63 ± 0.30 
26.09 ± 1.44 
8.58 ± 0.60 
52.51 ± 3.36 
27 ± 4 
24 ± 2 
33 ± 3 
27 ± 2 
other studies using similar sites (12, 18, 32). One potential 
explanation for regional differences in sweating over the body 
includes  differences  in  heat-activated  sweat  gland  (HASG) 
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Fig. 3. Regional skin blood flow (%CVCmax) during whole body heating to 1°C 
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output. Inoue and Shibasaki (12) observed little variation in 
HASG densities during passive heating of young, healthy 
males but found local sweat gland output to correspond closely 
with RSR. The authors observed similar RSR values on the 
back, thigh, and forearm compared with the present data during 
a 60-min passive heating protocol, providing support for sweat 
gland output as a likely explanation for the regional variation 
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in the present sweating data. 
One of the primary aims of this study was to examine the 
relation between RSR and SkBF during both thermal and 
pharmacological stimuli. In doing so, we were interested in 
quantified sweating rates versus quantified SkBF, which may 
be examined using absolute data (Fig. 2). Since MAP did not 
vary throughout the heating protocol, we have presented the 
regional SkBF data in arbitrary LDF units, as similarly pre- 
sented by other authors (12). Contrary to our hypothesis, 
absolute SkBF (LDF) was similar between sites throughout 
passive heating. We originally hypothesized that there would 
be greater cutaneous vasodilation in regions of higher sweating 
rates. Cutaneous vasodilation is the initial response to eleva- 
tions in skin and/or core body temperature, acting to increase 
convective heat loss to the environment. When elevations in 
core temperature persist, sweat is produced in the secretory coil 
of eccrine sweat glands from an ultrafiltrate of blood plasma 
before being secreted onto the skin surface to allow evapora- 
tive cooling. It therefore seemed logical that areas of greatest 
sweating would require a higher blood flow for ultrafiltrate 
production. Inoue and colleagues (13) similarly observed dis- 
crepancies between regions of high RSR and SkBF in young, 
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Fig. 2. Regional sweating 
rates (mg·min-1·cm-2) and 
LDF during whole body 
heating to 1°C rise in oral 
temperature (Tor) at 
ventral forearm (A), thigh 
(B), abdomen (C), and 
lower back (D). Regional 
sweating values 
significantly different 
from lower back, *P < 
0.05, **P < 0.01, ***P < 
0.001; significantly 
different from  abdomen  
site,  †P  < 0.05, ††P  < 
0.01,  †††P  < 0.001; 
significantly different 
from arm, ‡P < 0.05, 
following Bonferroni 
correction to adjust for 
multiple comparisons. 
healthy subjects. Notably, despite similarities in RSR com- 
pared with the present study, these authors observed regional 
differences in SkBF during the heating protocol. They found 
the greatest SkBF on the thigh, followed by the forearm, and 
the lowest values on the back and chest. It is unclear why there 
is such a discrepancy compared with the present data. Inoue 
and Shibasaki (13) normalized regional SkBF as percent base- 
line (%LDFbaseline) in conjunction with RSR and noted differ- 
ences between sites, which may reflect potential differences in 
baseline values. The present data illustrated small differences 
in baseline SkBF, although these values were not significant 
following correction for multiple comparisons. Similar dis- 
crepancies with the present data are observed by Inoue and 
Shibasaki (12) in an earlier study examining age-related dif- 
ferences in sweating and SkBF in which data are presented in 
absolute terms (LDF). Although SkBF data are typically nor- 
malized to maximum or baseline values when examining 
vascular control, in the present study it is more pertinent to 
express values of flow when considering the functional relation 
between sweating and SkBF. The presentation of both LDF 
units and %CVCmax in the present study negate data normal- 
ization as an issue for comparison with the literature. It would 
therefore seem likely that methodological issues may contrib- 
ute to such differences. In particular, the use of a water- 
perfused suit in the present study elicits a greater mean Tsk
compared with heating the lower legs in a water bath (12, 
13).  Modifi of local sweating rate and SkBF by 
alterations in local skin temperature are widely recognized 
and may help explain some of the discrepancies with the 
literature (27, 29, 40). 
A further consideration is the use of both males and females 
in the present data, although this was not an aim of the study, 
and we are underpowered to statistically examine sex differ- 
ences in RSR and SkBF. When considered separately, females 
appear to have slightly higher sweating rates at the abdomen 
and back and slightly delayed sweating thresholds at the arm 
and leg compared with the males during heating. No differ- 
ences were present in absolute flow between sexes, and only a 
slightly higher normalized blood flow (%CVCmax) was ob- 
served on the lower back in females. Both SkBF and RSR 
followed similar regional patterns in both males and females 
during passive heating and are consistent with regional patterns 
observed in recent literature examining RSR variation over the 
body (24, 34, 35). Despite V̇ O2max  values being similar be- 
tween sexes, males and females were not matched for factors 
such as anthropometric characteristics. Making a direct com- 
parison between sexes may therefore be misleading and is 
beyond the scope of this study. 
In the present study, regional sweating and SkBF cholinergic 
sensitivity were investigated to compliment the physiologically 
relevant whole body heating data. A number of studies have 
investigated cutaneous blood flow and sweating responses to 
local administration of ACh, methacholine (MCh), and in 
combination with acetylcholinesterase, utilizing the dorsal or 
ventral forearm as a measurement site (17, 18, 33). Consistent 
with literature on the forearm (18), in the present study in- 
creases in SkBF were elicited at lower concentrations of ACh 
compared with sweating at all sites. No differences in absolute 
SkBF were observed between sites; however, differences in 
EC50 were present between sites. The differences in EC50 
suggest regional variation in vascular cholinergic sensitivity. 
Taken together with the whole body heating data, the earlier 
cutaneous vasodilation versus sweating thresholds may be 
explained by differences in cholinergic sensitivity between the 
two responses. This still fails to explain the regional relation 
between sweating and SkBF upon exposure to a thermal 
stimulus. No correlation was present between SkBF and RSR 
during the ACh dose response, yet the two responses were 
strongly correlated at all sites during the initial phase of whole 
body heating. It would therefore appear that increases in SkBF 
are necessary to increase sweating, but that the two responses 
diverge with greater elevations in Tor. Taken together, these 
physiological and pharmacological data may indicate possible 
differences in control mechanisms, particularly in the latter 
stages of heating. Cutaneous vasodilation stimulated via cho- 
linergic nerves is partially mediated through release of an 
unknown cotransmitter (15), and by putative vasodilator pep- 
tides, such as VIP, released upon sudomotor nerve activation 
(36). The release of cotransmitters and other vasoactive sub- 
stances in addition to ACh may help explain some of the 
regional variation in vasomotor and sudomotor responses dur- 
ing heat stress; however, additional studies are necessary to 
explore the precise neurovascular signaling. 
 
Limitations 
The pairing of the MD technique with sweat capsules may 
have directly affected the regional sweat rate being measured. 
The MD fiber may potentially block a number of sweat glands 
in the skin under the capsule, causing the RSR to be lower. 
There is no way of identifying if this has occurred. Data from 
the present study are consistent with literature values using 
sweat capsules without MD fibers, and with other techniques, 
suggesting the effect of the fibers on RSR to be minimal or at 
least relatively consistent across sites. Second, the depth of MD 
fiber insertion was kept as consistent as possible. The depth on 
the abdomen was slightly deeper than the other sites, although 
we do not believe this significantly affected the outcome of the 
data. Maximal sweating rates may not have been achieved 
using a 100 mM ACh concentration during the present dose- 
response protocol, with regional differences in sensitivity be- 
ing missed at the higher concentrations. Other authors have 
obtained maximal sweat rates on the ventral forearm with a 1 
M concentration of ACh (18). It does however seem unlikely 
that such large variation in RSR would emerge between the 
present data and perfusion of 1 M ACh concentration to 
explain the observed variation between sites during exposure to 
thermal stimuli. 
The use of sublingual temperature to estimate core temper- 
ature thresholds for sweating may not be the most precise 
measure. However, regional comparisons were made between 
sites within each subject (repeated measures), therefore, any 
lag time or limitations in the measurement would similarly 
affect each site. Furthermore, the threshold values in the 
present study are consistent with literature values (22, 40). 
Finally, despite the present study including both male and 
female data, it was not the aim of this study to examine sex 
differences and is underpowered to do so. Considerable debate 
surrounds the presence of sex differences in thermoregulatory 
function, which although beyond the scope of this paper, 
certainly warrants future investigation. 
Perspectives and Significance 
When exposed to a thermoregulatory challenge, vasodilation 
and eccrine sweating are stimulated to maintain core body 
temperature. These responses are not uniform over the body 
and do not show a uniform dysfunction with aging and a 
number of pathological conditions. Few studies have addressed 
regional variation in sweating and SkBF, typically using a 
single body site to represent whole body responses. The results 
from the present study contribute novel data to improve our 
understanding of regional variation in vasomotor and sudomo- 
tor responses to pharmacological and physiological stimuli. 
Collectively they suggest that regional variation in sweating 
and SkBF is unlikely to be attributable to differences in 
cholinergic sensitivity and is more likely due to the role of a 
putative cotransmitter and due to variation in output per gland 
for sweating responses. Understanding these responses and 
their putative relation in a young, healthy population forms the 
basis for a greater understanding of mechanisms of dysfunction 
in disease states. This is particularly pertinent to the increas- 
ingly aging population and disease states such as diabetes 
mellitus. Research has demonstrated significant age-related and 
pathology-related decrements in thermoregulatory re- sponses 
during heat stress, for example, during heat waves, increasing 
susceptibility to heat-related illness and injury. 
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